2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Circulation. 2018 Sep 25;138(13):e272-e391. doi: 10.1161/CIR.0000000000000549.
No abstract available

Keywords: AHA Scientific Statements; CT imaging; ECG; MR imaging; acute coronary syndrome; ambulatory ECG monitoring; antiarrhythmic drug therapy; arrhythmogenic cardiomyopathy; athletes; cardiac electrophysiology; cardiac resynchronization therapy; cardiomyopathy; catheter ablation; congenital heart disease; echocardiography; electrophysiological testing; genetic arrhythmias; guidelines; heart failure; imaging; implantable and external cardioverter devices; implantable cardioverter-defibrillator; medication-induced arrhythmias; myocardial infarction; premature ventricular beats; resuscitation; sarcoidosis; specific pathology (eg, congenital heart disease, myocarditis, renal failure); stable coronary artery disease; sudden cardiac arrest; sudden cardiac death; torsades de pointes; ventricular fibrillation; ventricular tachycardia.

Publication types

  • Practice Guideline

MeSH terms

  • American Heart Association
  • Cardiology / standards*
  • Consensus
  • Death, Sudden, Cardiac / prevention & control*
  • Evidence-Based Medicine / standards
  • Humans
  • Risk Factors
  • Tachycardia, Ventricular / complications
  • Tachycardia, Ventricular / diagnosis
  • Tachycardia, Ventricular / mortality
  • Tachycardia, Ventricular / therapy*
  • Treatment Outcome
  • United States
  • Ventricular Fibrillation / complications
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / mortality
  • Ventricular Fibrillation / therapy*
  • Ventricular Premature Complexes / complications
  • Ventricular Premature Complexes / diagnosis
  • Ventricular Premature Complexes / mortality
  • Ventricular Premature Complexes / therapy*